Success Metrics

Active Trials
1(50%)

Phase Distribution

Ph phase_3
1
50%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution1 total trials
Phase 3Large-scale testing
1(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

2

all time

Status Distribution
Active(2)

Detailed Status

Recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
2
Active
1
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 31 (100.0%)

Trials by Status

recruiting150%
enrolling_by_invitation150%

Recent Activity

1 active trials
Showing 2 of 2
enrolling_by_invitation

Innovative Administration of Long-Acting Injectables for HIV Treatment Enhancement at Home

NCT06488846
recruitingphase_3

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

NCT06694805

Clinical Trials (2)

Showing 2 of 2 trials
NCT06488846

Innovative Administration of Long-Acting Injectables for HIV Treatment Enhancement at Home

Enrolling By Invitation
NCT06694805Phase 3

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

Recruiting

All 2 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
2